Clinical Trial Update: Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating serlopitant for chronic pruritus of unknown origin has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus of Unknown Origin

Drugs mentioned

• Serlopitant (serlopitant)

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Pruritus | Phase 2 | Status: COMPLETED | Results posted: 2020-09-23